NIKA PHARMACEUTICALS, INC (President, CEO, CFO) made both purchases and sales at NIKA PHARMACEUTICALS, INC
Purchased 11.49M shares and sold 22.55M shares — review individual transaction dates and prices for directional context.
Preferred A Stock
Shares
+10M
Price / share
$3M
Trade value
$30T
% of position
Common
Shares
+11.49M
Price / share
$0.01
Trade value
$137.87K
% of position
Common
Shares
+333.18M
Price / share
—
Trade value
—
% of position
Common
Shares
−7M
Price / share
$0.02
Trade value
$140K
% of position
Common
Shares
−1.25M
Price / share
$0.02
Trade value
$25K
% of position
Common
Shares
−3M
Price / share
$0.04
Trade value
$111K
% of position
Common
Shares
−6.30M
Price / share
$0.01
Trade value
$63K
% of position
Common
Shares
−1.50M
Price / share
$0.01
Trade value
$15K
% of position
Common
Shares
−3.50M
Price / share
$0.02
Trade value
$56K
% of position
Net shares
+332.12M
Net value
$30T
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Preferred A Stock Direct | 4/13/2022 | J · J | +10M | $3M | $30T | New position | 0.00 | 10M |
| Common Direct | 4/13/2022 | P · Purchase | +11.49M | $0.01 | $137.87K | New position | -11.49M | N/A |
| Common Direct | 7/20/2022 | J · J | +333.18M | — | — | New position | -333.18M | N/A |
| Common Direct | 9/12/2022 | S · Sale | −7M | $0.02 | $140K | New position | 7M | N/A |
| Common Direct | 9/26/2022 | S · Sale | −1.25M | $0.02 | $25K | New position | 1.25M | N/A |
| Common Direct | 10/24/2022 | S · Sale | −3M | $0.04 | $111K | New position | 3M | N/A |
| Common Direct | 1/10/2023 | S · Sale | −6.30M | $0.01 | $63K | New position | 6.30M | N/A |
| Common Direct | 1/31/2023 | S · Sale | −1.50M | $0.01 | $15K | New position | 1.50M | N/A |
| Common Direct | 6/2/2023 | S · Sale | −3.50M | $0.02 | $56K | New position | 3.50M | N/A |
| Total | +332.12M | $30T | ||||||